Copyright: ©Author(s) 2026.
World J Meta-Anal. Mar 18, 2026; 14(1): 118496
Published online Mar 18, 2026. doi: 10.13105/wjma.v14.i1.118496
Published online Mar 18, 2026. doi: 10.13105/wjma.v14.i1.118496
Table 2 Risk of bias assessment of included randomized controlled trials (RoB 2.0)
| Ref. | Randomization | Deviations from intended interventions | Missing data | Outcome measurement | Selective reporting | Overall risk |
| Mullens et al[12] | Low | Low | Low | Low | Low | Low |
| Cox et al[13] | Low | Low | Low | Low | Some concerns | Some concerns |
| Trullàs et al[14] | Low | Low | Low | Low | Low | Low |
| Cox et al[15] | Low | Some concerns | Low | Some concerns | Low | Some concerns |
| Damman et al[16] | Low | Low | Low | Low | Some concerns | Some concerns |
| Voors et al[17] | Low | Low | Low | Low | Low | Low |
| Butler et al[18] | Low | Low | Low | Low | Low | Low |
| Chen et al[19] | Low | Low | Low | Low | Low | Low |
- Citation: Patel V, Zameer R, Kumar B, Das M. Adjunctive pharmacologic therapies for diuretic resistance in acute decompensated heart failure: Systematic review of randomized trials. World J Meta-Anal 2026; 14(1): 118496
- URL: https://www.wjgnet.com/2308-3840/full/v14/i1/118496.htm
- DOI: https://dx.doi.org/10.13105/wjma.v14.i1.118496